Status:
COMPLETED
Standardized Patients to Measure and Address Intersectional Stigma
Lead Sponsor:
University of Minnesota
Conditions:
Hiv
HIV Infections
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
This study aims to develop and evaluate an intervention to reduce enacted stigma in healthcare settings aimed at people living with HIV (PLWH) and men who have sex with men (MSM) in China. Enacted sti...
Detailed Description
Standardized patients, or trained actors from the community, will conduct a baseline round of unannounced clinic visits with consenting providers for the purposes of observing their clinical performan...
Eligibility Criteria
Inclusion
- Eligible facilities will be those with:
- formal government accreditation as a medical center (a basic tenet of all public hospitals in China); and
- possession of an accredited on-site laboratory with capacity to provide enzyme-linked immunosorbent assay testing for HIV, treponemal (e.g. Treponema pallidum particle agglutination) and non-treponemal tests (e.g. rapid plasma regain) for syphilis.
- Within eligible and consenting facilities, eligible providers will be those who are licensed at the time of the study to practice dermatovenereology in China.
Exclusion
- none
Key Trial Info
Start Date :
November 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT04896216
Start Date
November 24 2020
End Date
September 30 2022
Last Update
July 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455